Citadel Advisors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Citadel Advisors’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,700	Closed	-$1.88M	–	9283
2014 Q4	$1.88M	Buy	18,700 +8,000	+75%	+$622K	﹤0.01%	2976
2014 Q3	$710K	Sell	10,700 -7,100	-40%	-$466K	﹤0.01%	4156
2014 Q2	$1.24M	Buy	17,800 +9,400	+112%	+$639K	﹤0.01%	3222
2014 Q1	$614K	Sell	8,400 -10,600	-56%	-$790K	﹤0.01%	4057
2013 Q4	$1.31M	Sell	19,000 -1,300	-6%	-$84.1K	﹤0.01%	2956
2013 Q3	$1.29M	Sell	20,300 -2,300	-10%	-$139K	﹤0.01%	2839
2013 Q2	$1.09M	Buy	+22,600	New	+$1.11M	﹤0.01%	3106

Citadel Advisors's CBST Position: Q1 2015 in Review

Citadel Advisors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 10,314 shares — an estimated $1.04M sold.

Citadel Advisors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $36.3M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Citadel Advisors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Citadel Advisors sold 10,314 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $1.04M.
Citadel Advisors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Citadel Advisors's CUBIST PHARMACEUTICALS INC position peaked at $36.3M in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Citadel Advisors's 13F filing for Q1 2015, filed 15 May 2015.